Skip to content
Menu
Home
Health & Tech
FDA & EMA
Oncology
Contact
Pharminent
Search for:
×
EHA 2025: Regeneron’s Lynozyfic with Amgen’s Kyprolis combo emerges for R/R MM
June 16, 2025
Post navigation
NICE approves GSK’s belantamab mafodotin for blood cancer →
← Investigational treatment shows promise for aggressive multiple myeloma
News – European Pharmaceutical Review
UCB commits major US biologics manufacturing investment
June 16, 2025
MHRA Class 2 medicine recalls – May/June 2025
June 13, 2025
Lancet study illustrates drug delivery “milestone”
June 12, 2025
FDA grants expanded approval for hepatitis drug
June 11, 2025
Construction begins on new WuXi microbial manufacturing site
June 10, 2025
Multi-billion-pound funding to accelerate UK’s high-growth sectors
June 9, 2025
Big Molecule Watch
Biosimilar Manufacturers to Expand Offerings in Europe and Japan
June 16, 2025
Third Circuit Holds That Granting Discovery Under Section 1782 Is Not a “Final” Judgment
June 13, 2025
Sandoz Launches PYZCHIVA® (Ustekinumab) Autoinjector in Europe
June 4, 2025
Samsung Bioepis Secures Marketing Approval in Korea for its Biosimilar to Amgen’s Bone Cancer Drug Xgeva
June 3, 2025
EMA Issues Positive CHMP Opinions for Fresenius Denosumab Biosimilars
June 2, 2025
Drug Channels
The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments (rerun)
June 17, 2025
The Top 15 U.S. Pharmacies of 2024: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)
June 16, 2025
Starting with the End in Mind: How Pharma Can Build a Smarter Path to Commercialization
June 13, 2025
The 340B Contract Pharmacy Market in 2025: Big Chains and PBMs Tighten Their Grip
June 10, 2025
Moving Beyond Mitigation: Cracking the Maximizer Code to Protect Patient Affordability
June 6, 2025
Pharmacist Salaries and Employment in 2024: Retail Employment Collapse Offset by Hospital Boom
June 3, 2025
Three Ways GoodRx Is Helping Pharmacies Increase Profitability and Drive Innovation
May 30, 2025
@ 2025 Pharminent. All rights reserved
Design by ThemesDNA.com
Scroll to Top